Cargando…
Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations
Systemic antibodies targeting tumor necrosis factor–α (TNF-α) and interleukin-17A (IL-17A) are effective in plaque psoriasis. Despite their popularity, safety concerns pose a challenge for systemic biologics. While anti–TNF-α and anti–IL-17A antibodies effectively inhibit respective proteins, we hyp...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439648/ https://www.ncbi.nlm.nih.gov/pubmed/32832675 http://dx.doi.org/10.1126/sciadv.abb6049 |